Wilson raised the full-year 2025 revenue guidance to $735 million to $740 million, representing 24% to 25% year-over-year growth. He stated, "This outlook contemplates continued strong volume growth ...
Revenue growth of +46% Improved results that reflect ongoing growth momentum Sharp reduction in losses and positive operating cash flow following an improvement in WCR Charwood Energy (ISIN: ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...
Hosted on MSN
Scorpio Daily Horoscope Today (Oct 23- Nov21), October 27, 2025: Positive energy will flow!
What will your day look like in terms of health, romance, finance and fortune? Read everything here. Scorpio Money Horoscope Today Financial results will improve, and your overall performance will be ...
AUSTIN, Texas, Oct. 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...
Background: The recently completed INSPIRE trial demonstrated that iruplinalkib improved progression-free survival and intracranial antitumor activity compared with crizotinib in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback